Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica

Reference

• ALVAREZ, L., IMPERIALE, F., SANCHEZ, S., MURNO, G. and LANUSSE, C., 2000, Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep. Veterinary Parasitology, 94, 75–89.
   PubMed Web of Science ®Google Scholar
• ALVAREZ, L., MOTTIER, L. and LANUSSE, C., 2004, Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium. Parasitology, 128, 73–81.
   PubMedGoogle Scholar
• ALVAREZ, L., MOTTIER, L., SANCHEZ, S. and LANUSSE, C., 2001, Ex vivo diffusion of albendazole and its sulphoxide metabolite into Ascaris suum and Fasciola hepatica. Parasitology Research, 87, 929–934.
   PubMed Web of Science ®Google Scholar
• ALVAREZ, L., SANCHEZ, S. and LANUSSE, C., 1999, In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetics behaviour in sheep. Journal of Veterinary Pharmacology and Therapeutics, 22, 77–86.
   Google Scholar
• ALVINERIE, M. and GALTIER, P., 1986, Assay of triclabendazole and its main metabolites in plasma by high-performance liquid chromatography. Journal of Chromatography, 374, 409–414.
   PubMedGoogle Scholar
• AVMA, 2001, Report of the AVMA panel on euthanasia. Journal of the American Veterinary Medical Association, 218, 669–696.
   PubMedGoogle Scholar
• BENNETT, J. and KOHLER, P., 1987, Fasciola hepatica: action in vitro of triclabendazole on immature and adult species. Experimental Parasitology, 63, 49–57.
   PubMed Web of Science ®Google Scholar
• BOGAN, J., KINABO, L., STRONG, M., FORMICA, C., GALTIER, P. and ALVINERIE, M., 1988, Pharmacokinetics of triclabendazole in cattle, sheep, goats, horses, ponies, donkeys, pigs and man. In Proceedings of the 4th Congress of the European Association for Veterinary Pharmacology and Toxicology, Budapest, Hungary, pp. 159–163.
   Google Scholar
• BORAY, J., CROWFOOT, P., STRONG, M., ALLISON, J., SCHELLENBAUM, M., VON ORELLI, M. and SARASIN, G., 1983, Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Veterinary Record, 113, 315–317.
   PubMed Web of Science ®Google Scholar
• BeSCHER, G., BOWEN, F., STRONG, M. and CROWFOOT, P., 1999, Efficacy of triclabendazole, its metabolites and other compounds in sheep. In Proceedings of the International Conference of the World Association for the Advancement of Veterinary Parasitology, abstract c.7.40.
   Google Scholar
• COLES, G., 1986, Anthelmintic activity of triclabendazole. Journal of Helminthology, 60, 210–212.
   PubMed Web of Science ®Google Scholar
• COURTNEY, C. and ROBERSON, E., 1995, Anticestodal and antinematodal drugs. In R. Adams (ed.), Veterinary Pharmacology and Therapeutics (Ames: Iowa State University Press), pp. 940–952.
   Google Scholar
• CROSS, H., RENZ, A. and TREES, A., 1998, In vitro uptake of ivermectin by adult male Onchocerca ochengi. Annals of Tropical Medicine and Parasitology, 92, 711–720.
   PubMed Web of Science ®Google Scholar
• DIXIT, A. and ROCHE, T., 1984, Spetrophotometric assay of the flavin-containing mono-oxigenase and changes in its activity in female mouse liver with nutritional and diurnal conditions. Archives of Biochemistry and Biophysics, 233, 50–63.
   PubMed Web of Science ®Google Scholar
• DoucH, P. and BUCHANAN, L., 1979, Some properties of the sulphoxidases and sulphoxide reductases of the cestode Moniezia expansa, the nematode Ascaris suum and mouse liver. Xenobiotica, 9, 675–679.
   PubMed Web of Science ®Google Scholar
• FETTERER, R. and REW, R., 1984, Interaction of Fasciola hepatica with albendazole and its metabolites. Journal of Veterinary Pharmacology and Therapeutics, 7, 113–118.
   PubMed Web of Science ®Google Scholar
• GALTIER, P., LARRIEU, G. and BEAUNE, P., 1986, Characterization of the microsomal cytochrome P-450 species inhibited in rat liver in the course of fascioliasis. Biochemical Pharmacology, 35, 4345–4347.
   PubMed Web of Science ®Google Scholar
• GIBALDI, M. and PERRIER, D., 1982, Pharmacokinetics (New York: Marcel Dekker), pp. 45-109. GOTTSCHALL, D., THEODORIDES, V. and WANG, R., 1990, The metabolism of benzimidazole anthelmintics. Parasitology Today, 6, 118–124.
   Google Scholar
• GROTHUSEN, A., HARDT, J., BRAUTIGAM, L., LANG, D. and BoCKE R., 1996, A convenient method to discriminate between cytochrome P450 enzymes and fiavin-containing mono-oxygenases in human liver microsomes. Archives of Toxicology, 71, 64–71.
   PubMed Web of Science ®Google Scholar
• HENNESSY, D., LACEY, E., STEEL, J. and PRICHARD, R., 1987, The kinetics of triclabendazole disposition in sheep. Journal of Veterinary Pharmacology and Therapeutics, 10, 64–72.
   PubMed Web of Science ®Google Scholar
• HENNESSY, D., PRICHARD, R. and STEEL, J., 1993, Biliary secretion and enterohepatic recycling of fenbendazole metabolites in sheep. Journal of Veterinary Pharmacology and Therapeutics, 16, 132–140.
   PubMedGoogle Scholar
• Ho, N., GEARY, T., RAUB, T., BARSHUM, C. and THOMPSON, D., 1990, Biophysical transport properties of the cuticle of Ascaris suum. Molecular and Biochemical Parasitology, 41, 153–166.
   PubMed Web of Science ®Google Scholar
• LANUSSE, C., NARE, B. and PRICHARD, R., 1993, Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole. Xenobiotica, 23, 285-295. LANUSSE, C. and PRICHARD, R., 1993, Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metabolism Reviews, 25, 235–279.
   PubMed Web of Science ®Google Scholar
• MAs-COMA, M., ESTEBAN, J. and BARGUES, M., 1999, Epidemiology of human fascioliasis: a review and proposed new classification. WHO Bulletin, 77, 340–346.
   PubMed Web of Science ®Google Scholar
• MCCRAKEN, R. and LIPKOWITZ, K., 1990, Structure—activity relationship of benzimidazole anthelmintics: a molecular modeling approach to in vivo drug efficacy. Journal of Parasitology, 76, 853–864.
   PubMedGoogle Scholar
• McMANus, M., STUPANS, I., BURGESS, W., KOENIG, J., HALL, P. and BIRKETT, D., 1987, Flavin-containing mono-oxygenase activity in human liver microsomes. Drug Metabolism and Disposition, 15, 256–261.
   PubMed Web of Science ®Google Scholar
• MORONI, P., BURONFOSSE, T., LONGIN-SAUVAGEON, C., DELATOUR, P. and BENOIT, E., 1995, Chiral sulfoxidation of albendazole by the fiavin adenine dinucleotide-containing and cytochrome P450-dependent mono-oxygenases from rat liver microsomes. Drug Metabolism and Disposition, 23, 160–165.
   Google Scholar
• MOTTIER, L., ALVAREZ, L., PIS, A. and LANUSSE, C., 2003, Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: correlation with their octanol—water partition coefficients. Experimental Parasitology, 103, 1–7.
   PubMedGoogle Scholar
• MOTTIER, L., MORENO, L., ALVAREZ, L., VIRKEL, G. and LANUSSE, C., 2004, Measurement of triclabendazole and its metabolites in liver flukes: method development and full validation. Journal of Pharmaceutical and Biomedical Analysis, 35, 991–999.
   PubMedGoogle Scholar
• PtHouRco, F., THOMAS, J. and JARRY, C., 2000, A microscale HPLC method for the evaluation of octanol—water partition coefficients in a series of new 2-amino-2-oxazolines. Journal of Liquid Chromatography and Research Technology, 23, 443–453.
   Google Scholar
• PRECIOUS, W. and BARRET, J., 1989, Xenobiotic metabolism in helminths. Parasitology Today, 5, 156–160.
   PubMedGoogle Scholar
• RAWDEN, H., KOKWARO, G., WARD, S. and EDWARDS, G., 2000, Relative contribution of cytochromes P-450 and fiavin-containing mono-oxygenases to the metabolism of albendazole by human liver microsomes. British Journal of Clinical Pharmacology, 49, 313–322.
   PubMed Web of Science ®Google Scholar
• ROBINSON, M., LAWSON, J., TRUDGETT, A., HOEY, E. and FAIRWEATHER, I., 2004, The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitology Research, 92, 205–210.
   PubMed Web of Science ®Google Scholar
• ROTHWELL, J. and SANGSTER, N., 1997, Haemonchus contortus: the uptake and metabolism of closantel. International Journal for Parasitology, 27, 313–319.
   PubMed Web of Science ®Google Scholar
• SMITH, P., KROHN, R., HERMANSON, G., MALLIA, A., GARTNER, F., PROVENZANO, M., FUJIMOTO, E., GOEKE, N., OLSON, B. and KLENK, D., 1985, Measurement of protein using bicinchoninic acid. Analytical Biochemistry, 150, 76–85.
   PubMed Web of Science ®Google Scholar
• SOLANA, H., RODRIGUEZ, J. and LANUSSE, C., 2001, Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites. Parasitology Research, 87, 275–280.
   PubMed Web of Science ®Google Scholar
• SOUHAILI EL AMRI H., FARGETTON, X., DELATOUR, P. and BATT, A., 1987, Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes. Xenobiotica, 17, 1159–1168.
   PubMed Web of Science ®Google Scholar
• VIRKEL, G., LIFSCHITZ, A., SALLOVITZ, J., Pis, A. and LANUSSE, C., 2004, Comparative hepatic and extra-hepatic enantioselective sulphoxidation of albendazole and fenbendazole in sheep and cattle. Drug Metabolism and Disposition (in press).
   Google Scholar